Tapewire

Nasdaq · USD

IXHL

Incannex Healthcare Inc.

Export transactions ↓
Tapewire entity
7349
SEC CIK
0001873875
Parsed reports
23

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 14, 2025 Filed Nov 14, 2025 06:14 UTC
Swan JosephCFO, Treasurer and Secretary
GrantCommon Stock, $0.0001 par value per share 869,565 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-110279 · ownership.xml · nonDerivative · entry 1

Swan Joseph · CIK 0002002769 · CFO, Treasurer and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 921,358

F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 289,855 Shares that vest on December 10, 2025, (ii) 289,855 Shares that vest on June 30, 2026; and (iii) 289,855 Shares that vest on June 30, 2027.

Read SEC document
November 14, 2025 Filed Nov 14, 2025 06:12 UTC
Latham JoelDirector · CEO and President
GrantCommon Stock, $0.0001 par value per share 22,608,692 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-110275 · ownership.xml · nonDerivative · entry 1

Latham Joel · CIK 0001997460 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,186,177

F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 5,652,173 Shares that vest in full on December 10, 2025, (ii) 5,652,173 Shares that vest in full on June 30, 2026, (iii) 5,652,173 Shares that vest in full on June 30, 2026 and (iv) 5,652,173 Shares that vest in full on June 30, 2027.

Read SEC document
November 14, 2025 Filed Nov 14, 2025 06:15 UTC GrantCommon Stock, $0.0001 par value per share 1,686,956 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-110284 · ownership.xml · nonDerivative · entry 1

Widdows Peter · CIK 0001997183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,957,803

F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027.

Read SEC document
November 14, 2025 Filed Nov 14, 2025 06:11 UTC GrantCommon Stock, $0.0001 par value per share 1,686,956 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-110271 · ownership.xml · nonDerivative · entry 1

Anastassov George · CIK 0001604392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,456,677

F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027.

Read SEC document
November 14, 2025 Filed Nov 14, 2025 11:18 UTC GrantCommon Stock, $0.0001 par value per share 11,302,608 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-110290 · ownership.xml · nonDerivative · entry 1

Valentine Troy · CIK 0001998126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,001,858

F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 2,825,652 Shares that vest in full on December 10, 2025, (ii) 2,825,652 Shares that vest in full on June 30, 2026, (iii) 2,825,652 Shares that vest in full on June 30, 2026 and (iv) 2,825,652 Shares that vest in full on June 30, 2027.

Read SEC document
November 14, 2025 Filed Nov 14, 2025 11:17 UTC
Clark RobertDirector
GrantCommon Stock, $0.0001 par value per share 1,686,956 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-110286 · ownership.xml · nonDerivative · entry 1

Clark Robert · CIK 0001997820 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,786,956

F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027.

Read SEC document
October 23, 2024 Filed Oct 24, 2024 16:49 UTC
Barbato Luigi M.Chief Medical Officer
GrantCommon Stock 100,476 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-090422 · ownership.xml · nonDerivative · entry 1

Barbato Luigi M. · CIK 0002041500 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,476

F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after October 21, 2024 and at the end of every twelve-month period thereafter over the remaining 24 months, subject to continued service for the Issuer on each vesting date.

Read SEC document
May 06, 2024 Filed Aug 2, 2024 06:10 UTC
Swan JosephCFO, Treasurer and Secretary
GrantRestricted Shares of Common Stock 50,793 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-064333 · ownership.xml · nonDerivative · entry 1

Swan Joseph · CIK 0002002769 · CFO, Treasurer and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,793

F1 · date: Award of restricted shares of which 16,931 restricted shares vested on June 30, 2024, 16,931 restricted shares will vest on June 30, 2025, and 16,931 restricted shares will vest on June 30, 2026, provided the Reporting Person is still employed on each vesting date.

F2 · kind: This Form 5 reports the award of 50,793 restricted shares by the Reporting Person pursuant to the Company's Equity Incentive Plan occurred on May 6, 2024.

Read SEC document
December 21, 2023 Filed Dec 21, 2023 20:50 UTC
Latham JoelDirector · CEO and President
GrantCommon Stock 1,340,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-23-097816 · ownership.xml · nonDerivative · entry 1

Latham Joel · CIK 0001997460 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,577,485

F1 · kind: Award of restricted stock of which 335,000 shares will vest on December 31, 2023, 335,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 335,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 335,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing employment on each vesting date.

Read SEC document
December 21, 2023 Filed Dec 21, 2023 20:53 UTC GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-23-097818 · ownership.xml · nonDerivative · entry 1

Widdows Peter · CIK 0001997183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,847

F1 · kind: Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.

Read SEC document
December 21, 2023 Filed Dec 21, 2023 20:49 UTC GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-23-097814 · ownership.xml · nonDerivative · entry 1

Anastassov George · CIK 0001604392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 769,721

F1 · kind: Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 01:47 UTC
Clark RobertDirector
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-23-097812 · ownership.xml · nonDerivative · entry 1

Clark Robert · CIK 0001997820 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · kind: Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 01:54 UTC GrantCommon Stock 670,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-23-097821 · ownership.xml · nonDerivative · entry 1

Valentine Troy · CIK 0001998126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 699,250

F1 · kind: Award of restricted stock of which 167,500 shares will vest on December 31, 2023, 167,500 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 167,500 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 167,500 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.